Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
4
×
deals
4
×
fda
4
×
life sciences
national blog main
biotech
clinical trials
national top stories
boston
new york
new york blog main
new york top stories
novartis
achromatopsia
alexion pharmaceuticals
alirocumab
alnylam pharmaceuticals
amgen
amyotrophic lateral sclerosis (als)
atrial fibrillation
autoimmune disorders
beta-thalassemia
bill cassidy
bluebird bio
boston scientific
clinical trial
complement system
cryterion medical
dna
evolocumab
food and drug administration
gene therapy
generalized myasthenia gravis
harvard pilgrim health care
hemophilia
immune-mediated necrotizing myopathy
inclisiran
investing
johnson & johnson
What
deal
4
×
acquire
drug
medicines
adding
age
agreed
alternative
atrial
autoimmune
bigger
biggest
billion
boston
brings
business
candidate
cash
cholesterol
come
company
compound
continues
cryterion
device
disease
emerging
expensive
fda
fibrillation
gave
gene
heart
j
johnson
lead
management
medco
meiragtx
morning
Language
unset
Current search:
deals
×
" boston top stories "
×
fda
×
deal
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion